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Craving and nicotine withdrawal syndrome (NWS) are components of 
the tobacco use disorder in DSM-5. They both appear after smoking 
cessation or an abrupt reduction in tobacco use, and they are 
associated with both short and long-term smoking-cessation outcomes. 
The aim of the present study was to examine the association of craving 
and withdrawal with smoking cessation at the end of the treatment 
and relapse at 3 months follow-up in a Spanish sample of smokers. 
The sample comprised 342 smokers (37.7% men; 62.3% women) 
receiving a cognitive-behavioral treatment for smoking cessation. 
The assessments of craving and withdrawal were conducted using the 
Minnesota Nicotine Withdrawal Scale. Abstainers at the end of the 
treatment, compared to non abstainers, showed significantly lower 
post-treatment withdrawal, and post-treatment craving. Furthermore, 
they had lower scores in pre-treatment nicotine dependence. Among 
abstainers, craving decreased significantly from pre-cessation levels, 
while in those participants who did not quit smoking it remained on the 
same levels. High nicotine dependence was a predictor of smoking at 
the end of the treatment, whereas high nicotine withdrawal predicted 
relapse at 3 months. Findings support the robust role of craving and 
NWS in smoking cessation and relapse, although they differ in their 
specific patterns of change over time.
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El craving y el síndrome de abstinencia de la nicotina (SAN) forman 
parte del trastorno por consumo del tabaco en el DSM-5. Ambos 
aparecen tras dejar de fumar o tras una reducción brusca del consumo 
de tabaco, y están relacionados con los resultados de dejar de fumar 
a corto y largo plazo. El objetivo del presente estudio fue analizar la 
relación del craving y del síndrome de abstinencia con dejar de fumar 
al final del tratamiento y con la recaída a los 3 meses de seguimiento 
en una muestra de fumadores españoles. La muestra estaba formada 
por 342 fumadores (37,7% hombres; 62,3% mujeres) que recibieron 
tratamiento cognitivo-conductual para dejar de fumar. La evaluación 
del craving y del síndrome de abstinencia se realizó a través de la 
escala Minnesota Nicotine Withdrawal Scale. Los abstinentes al final 
del tratamiento, comparados con los no abstinentes, mostraron un 
síndrome de abstinencia y un craving significativamente menor al 
finalizar el tratamiento. Además, los abstinentes tenían puntuaciones 
menores en dependencia de la nicotina antes del tratamiento. 
Entre los abstinentes, el craving descendió significativamente desde 
los valores presentados antes de dejar de fumar, mientras que en 
los participantes que no dejaron de fumar los valores de craving 
permanecieron en los mismos niveles. La dependencia de la nicotina 
elevada fue el predictor de fumar al final del tratamiento, mientras 
que el síndrome de abstinencia de la nicotina elevado fue predictor 
de la recaída a los 3 meses. Los resultados apoyan el papel robusto del 
craving y del SAN en dejar de fumar y en la recaída, aunque difieren 
en sus patrones de cambio a lo largo del tiempo.
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Nicotine withdrawal syndrome (NWS) is consi-dered an important component of tobacco de-pendence (Baker, Piper, McCarthy, Majeskie, & Fiore, 2004; Hughes, Higgins, & Hatsukami, 
1990). It includes subjective, cognitive, and physiological 
symptoms that appear when giving up smoking, which make 
it more difficult to maintain abstinence (Shiffman, West, 
& Gilbert, 2004) and it plays an important role in relapse 
(Piasecki, Jorenby, Smith, Fiore, & Baker, 2003b).  In the 
recent published DSM-5 (American Psychiatric Association 
[APA], 2013), the signs or symptoms of NWS are irritabil-
ity, frustration or anger, anxiety, difficulty concentrating, 
increased appetite, restlessness, depressed mood, and in-
somnia. 
Craving is considered a criterion for the diagnostic of 
tobacco use disorder in DSM-5 (APA, 2013). However, 
previously, craving was not consider as a formal criterion 
of nicotine dependence or NWS in DSM-IV (APA, 1994), 
nevertheless it was included by different researchers in the 
scales that assess this syndrome (Etter & Hughes, 2006; West 
& Hajek, 2004). Craving was not included in the DSM-IV 
as a symptom of withdrawal because of its inconsistent as-
sociation with tobacco abstinence (Hughes, Higgins, & Bic-
kel, 1994). Compared to other withdrawal features, craving 
seems to have a distinctive time course (Gilbert et al., 1998; 
Hughes, 1992; Shiffman et al., 1997). 
Accordingly, it has been considered craving as a subjec-
tive experience of a desire or intense need for substance 
use (APA, 2013), as an important symptom of tobacco de-
pendence (Baker, Breslau, Covey, & Shiffman, 2012; Tiffany, 
Warthen, & Goedeker, 2009), and there is evidence that it 
plays a causal role in smoking relapse (Baker et al., 2004; 
Shiffman, Paty, Gnys, Kassel, & Hickcox, 1996).
The inability to cope with NWS and craving when quit-
ting smoking appears to account for the failure of many ces-
sation attempts (Ferguson, Shiffman, & Gwaltney, 2006).  
In addition, several studies indicate that the pattern, du-
ration, and severity of NWS and craving experienced by 
smokers who are abstinent during the first day or the first 
weeks after quitting are significant predictors of relapse in 
smokers (Allen, Bade, Hatsukami, & Center, 2008; Hughes, 
2007; Piasecki et al., 2003b; Shiffman et al., 1997). For exam-
ple, Allen et al. (2008) found that higher levels of NWS and 
craving were associated with relapse. Piasecki et al. (2003b) 
reported that subjects who relapse reported more severe 
NWS during smoking abstinence than did non relapsers. 
The purpose of the current study was to assess the ge-
neralizability of these constructs by analyzing the relations-
hip of craving and NWS with smoking cessation at the end 
of the treatment, and with relapse at 3 months follow-up, 
in a sample of Spanish smokers who received a cognitive 
behavioral smoking cessation intervention.  Compared to 
the United States, where much of the previous research oc-
curred, Spain has a higher prevalence of smoking (24% vs 
19%; CDC, 2012; Ministerio de Sanidad, 2013), and Spanish 
smokers, on average, are less nicotine-dependent (de Leon, 
Becoña, Gurpegui, Gonzalez-Pinto, &  Diaz, 2002).  Given 
these differences, along with more general cultural diffe-
rences, confirmation of the role of nicotine dependence 
and NWS upon smoking cessation in this population would 
strengthen the construct validity of addiction models that 
emphasize these factors, including DSM-5.
Methods
Participants
The study sample consisted of male and female Spani-
sh smokers (N = 342) who requested smoking cessation 
treatment at the Smoking Cessation Unit of the Faculty 
of Psychology at the University of Santiago de Composte-
la (Spain). Recruitment of the smokers was carried out by 
advertisements in the media (radio, press and local televi-
sion), through other smokers who had previously sought 
treatment, or through referral from general practitioners. 
Selection of participants used the following inclusion crite-
ria: at least 18 years of age; desire to participate in the treat-
ment program; smoking ≥ 10 cigarettes per day; and having 
completed the questionnaires in the pretreatment assess-
ment. Exclusion criteria were: a diagnosis of a severe mental 
illness (bipolar disorder and/or psychotic disorder); concu-
rrent dependence on other substances (cocaine, cannabis, 
and/or heroin); having participated in the same or similar 
treatment over the previous year; having received another 
type of effective smoking cessation treatment (nicotine re-
placement therapy, bupropion, varenicline) in the past year; 
suffering from a severe physical pathology that would requi-
re immediate medical intervention (e.g., recent myocardial 
infarction, pneumothorax); smoking tobacco other than ci-
garettes (e.g., cigars); refusing to be video-recorded during 
the sessions; and failing to attend the first treatment session. 
From an initial sample of 412 smokers, 70 were excluded 
based on exclusion criteria, with the final sample compri-
sing 342 smokers (37.7% men and 62.3% women) with a 
mean age of 41.58 years (SD = 10.87).
Measures
All participants completed the Smoking Habit ques-
tionnaire (Becoña, 1994), which obtains information on 
sociodemographic variables (e.g., gender, age) and aspects 
related to smoking and smoking history (e.g., number of 
cigarettes smoked per day, number of years smoking).
For the assessment of nicotine dependence (ND) we used 
the Fagerström Test for Nicotine Dependence (FTND, Heather-
ton, Kozlowski, Frecker, & Fagerstrom, 1991; Spanish ver-
sion by Becoña & Vázquez, 1998). 
To assess nicotine withdrawal, the Spanish version of the 
Minnesota Nicotine Withdrawal Scale (Hughes & Hatsukami, 
1998) was used (see Table 1). This scale consists of eight 
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items (irritability, angry or frustrated; anxiety or tension; di-
fficulty concentrating; restlessness or impatience; increased 
appetite, hungry or weight gain; depressed mood or sad; in-
somnia, sleep problems or awakening at night; and, desire 
or craving to smoke) measured with a Likert scale ranging 
from 0 (no symptoms) to 4 (severe symptoms). The sum of 
the items, minus the craving score which is assessed sepa-
rately, was used to assess overall NWS. This scale has been 
found to have fair to good internal consistency with alpha 
ranging from .80 to .83 (Toll, O’Malley, McKee, Salovey, & 
Krishnan-Sarin, 2007). Craving was assessed as a single item 
on the scale, due to evidence suggesting that craving patter-
ns are distinct from other symptoms of withdrawal (Hughes 
& Hatsukami, 1998), and scores were analyzed separately. 
We used the Micro+ Smokerlyzer® (Bedfont Scientific 
Ltd, Sittingbourne, UK) to measure carbon monoxide (CO) 
in expired air, to corroborate self-reported abstinence at 
the end of the treatment and at 3-month follow-up (cut-off 
point of < 10 ppm to be considered a non-smoker) (West, 
Hajek, Stead, & Stapleton, 2005).
Procedure
At the initial assessment, we administered the measure-
ments described above. Minnesota Nicotine Withdrawal Scale 
was administered again for the assessment of craving and 
NWS at the end of the treatment and at 3 months follow-up. 
All smokers gave their informed consent to participate in 
the research, and the Bioethics Committee of the University 
of Santiago de Compostela authorized the study. 
The psychological treatment administered was the 
Smoking Cessation Program by Becoña (2007), a manualized 
cognitive-behavioral treatment that comprises 6 group-for-
mat sessions over six weeks (one session per week). The 
treatment was administered by psychologists trained in its 
application.
We considered that a participant relapsed when he or 
she had been abstinent for at least 24 hours at the end of 
the treatment, but reported any smoking during the 7 days 
prior to the date of the 3-month follow-up (Velicer, Prochas-
ka, Rossi, & Snow, 1992).
Data analysis
Analyses were conducted using SPSS 20. Descriptive statistics 
were used to describe demographic and smoking history cha-
racteristics of the participants. Comparisons of clinical charac-
teristics pre- and post-treatment and at 3-months follow-up were 
conducted using t-test. The effect size (ES) of significant results 
is reported in the tables (d = 0.20-0.49 small ES, d = 0.50-0.79 
medium ES, and d = 0.80 and above large ES, Cohen, 1988). 
For testing the change in craving and NWS over the three 
times points (pre, post-treatment and 3 months follow-up), 
among abstainers and relapsers at 3 months follow-up, mixed 
factor analyses of variance (ANOVAs) were conducted, with 
time as the repeated factor and smoking status at 3 months 
follow-up (abstainer-relapser) as the between-subjects factor. 
We used Bonferroni’s post-hoc tests for verifying the exis-
tence of significant differences in the pairwise comparison.
Additionally, the role of craving and NWS in predicting 
smoking at the end of the treatment and smoking relapse at 
3 months follow-up was analyzed using stepwise logistic re-
gression (forward conditional). According to this method, 
variables are selected in the order in which they maximize 
the statistically significant contribution to the model. The 
significance level for all analyses was set at 0.05.
Results
Sample characteristics
Participants in this study (N = 342) smoked a mean of 
21.62 cigarettes per day (SD = 8.16, range: 10-40). FTND 
Table 1 
Spanish version of the ‘Minnesota Nicotine Withdrawal Scale’
Por favor, indique si en las últimas 24 horas, ha sentido usted alguno de estos síntomas
Nada Escaso Leve Moderado Severo
0 1 2 3 4
1. Enfado/Irritabilidad/Frustración
2. Ansiedad/Nerviosismo
3. Dificultad de concentración 
4. Impaciencia/Intranquilidad
5. Incremento del apetito, hambre, ganancia de peso
6. Insomnio, problemas con el sueño, despertar a media noche
7. Ánimo deprimido, tristeza
8. Deseo o necesidad de fumar
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mean as 5.28 (SD = 2.12), NWS mean was 7.18 (SD = 6.21), 
and craving mean was 2.92 (SD = 1.02).
Smoking status at the end of the treatment and its 
relationship with NWS and craving
We had data at the end of the treatment from 312 partici-
pants (91.23% of the initial sample). Of them, 201 (64.42%) 
were abstinent and 111 (35.58%) continued smoking. 
Among those who continued smoking a significant reduc-
tion in the number of cigarettes at the end of the treatment 
was produced (M = 24.85, SD = 9.37 pre-treatment, and M = 
7.93, SD = 6.74, post-treatment; t = 18.34, p < .001). 
Regarding variables assessed pre-treatment (ND, NWS and 
craving) significant differences were found at the end of the 
treatment for only ND; abstainers had lower ND than partici-
pants who continued smoking (M = 4.84, SD = 2.09 for abstain-
ers, and M = 5.88, SD = 1.97, for smokers; t = -4.30, p < .001). 
On NWS and craving post-treatment, significant differ-
ences were observed by final smoking status. Abstainers pre-
sented lower NWS (M = 8.15, SD = 5.08 for abstainers, and M 
= 10.98, SD = 6.58 for smokers; t = -3.94, p < .001), and lower 
craving (M = 1.84, SD = 1.13 for abstainers, and M = 2.73, SD 
= 1.05 for smokers; t = -6.84, p < .001), than smokers. 
Smoking status at 3 months follow-up and its rela-
tionship with NWS and craving
Taking as a reference the number of participants who 
were abstinent at the end of the treatment (n = 201), we 
obtained complete data for 162 participants on NWS and 
craving pre-treatment, post-treatment and at 3 months fol-
low-up. Of these 106 (65.43%) remained abstinent and 56 
(34.57%) relapsed by 3 months follow-up.  
At 3 months follow-up, we found significant differenc-
es on NWS and craving assessment between abstainers and 
relapsers. Those participants who relapsed at 3 months fol-
low-up presented higher NWS (M = 6.02, SD = 6.30 for ab-
stainers, and M = 9.75, SD = 6.77 for relapsers; t = -3.46, p < 
.001), and higher craving (M = 0.81, SD = 1.05 for abstainers, 
and M = 2.66, SD = 1.08 for relapsers; t = -10.53, p < .001), than 
participants who remained abstinent at 3 months follow-up.
Evolution of craving and NWS from the beginning 
to the end of treatment (n = 312)
Among end-of-treatment abstainers (n = 201), we ob-
served that the pattern of change of craving was different 
than that of NWS. Craving in abstainers decreased until 
reaching values below pre-treatment levels (2.97 pre-treat-
ment vs. 1.84 post-treatment; t = -11.08, p < .001). However, 
NWS increased (6.53 pre-treatment, vs. 8.15 post-treatment; 
t = -3.64; p < .001). 
Among continuing smokers, craving remain stable (2.89 
pre-treatment vs. 2.73 post-treatment; t = 1.31, n.s.), but 
NWS increased significantly (8.04 pre-treatment vs. 10.98 
post-treatment; t = - 4.19, p < .001).
Evolution of craving and NWS from treatment on-
set to the 3 months follow-up (n = 201)
As seen in Table 2 we found no differences between those 
who abstained versus relapsed at 3-months on either pre-
treatment craving or NWS. At posttreatment, only NWS di-
ffered between the groups (7.34 for abstainers vs. 9.89 for 
relapsers). By 3 months follow-up, we observed significant 
differences between abstainers and relapsers on both varia-
bles. Those who relapsed had a higher craving and higher 
NWS than those who remained abstinent.
With respect to NWS, the ANOVA indicated a significant 
effect of the time factor (pre, post and 3 months) and of 
the group factor (abstainers and relapsers), and a significant 
time x group interaction. Thus, among relapsers (n = 56), 
after the application of post hoc Bonferroni correction (see 
Figure 1), we found significant differences between NWS pre 
and post (p < .001) and NWS pre and 3 months follow-up (p 
< .05), but no differences between NWS post and 3 months 
follow-up. In abstainers (n =106), no significant differences 
were found on NWS across the different time points.
With respect to craving, we found a significant time 
effect, a significant group effect, and a significant time x 
group interaction. Among relapsers (see Figure 2), a signifi-
Figure 1. Nicotine withdrawal syndrome (NWS) over the three 
time points among relapsers and abstainers.
Figure 2. Craving over the three time points among relapsers 
and abstainers.
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Table 2 
Differences in craving and nicotine withdrawal syndrome (NWS) at three time points (pre-treatment, post-treatment, and 3 months 
follow-up) among abstainers and relapsers
3 months follow-up (n = 162)           
Abstainers
(n = 106; 65.43%)
Relapsers
(n = 56; 34.57%) t             95% CI d
Lower Upper
Pre-treatment assessment
NWS, Mean (SD) 6.08 (5.41) 7.14 (5.49) -1.19 -2.84 0.70
Craving, Mean (SD) 3.01 (0.82) 2.89 (0.99) 0.76 -0.19 0.42
Post-treatment assessment
NWS, Mean (SD) 7.34 (4.89) 9.89 (5.52) -3.02** -4.22 -0.88 0.23
Craving, Mean (SD) 1.77 (1.12) 1.96 (1.04) -1.06 -0.55 0.17
3 month follow-up assessment
NWS, Mean (SD) 6.02 (6.30) 9.75 (6.77) -3.49*** -5.84 -1.62 0.27
Craving, Mean (SD) 0.81 (1.05) 2.66 (1.08) -10.53*** -2.20 -1.50 0.64
 NWS Anova Time (pre, post, 3 
months)
F (2,159) = 7.28***
           Group (abstainer, relapses) F (1,160) = 11.83***
Interaction (time x group) F (2,159) = 3.14*
 Craving Anova Time (pre, post, 3 
months)
F (2,159) = 68.74***
Group (abstainer, relapses) F (1,160) = 37.56***
           Interaction (time x group) F(2,159) = 43.27***
Note. NWS = nicotine withdrawal syndrome.  
* p <.05;** p < .01;***p < .001.
Table 3 
Logistic regression analysis output as predictors of smoking status at the end of treatment (n = 312) and at 3 months follow-up (n = 162)
Ba Wald p value OR OR (95% CI)
End of the treatment
                                         ND, FTND (≥ 6) pre-treatment 0.828 11.772 .001 2.28 1.42-3.67
    Constant -0.986 33.289 .001 0.37
3 months of follow-up
     NWS-post 0.094 8.258 .004 1.09 1.03-1.02
   Constant -1.445 18.555 .001 0.23
Note. CI = confidence interval; FTND = Fagerström Test for Nicotine Dependence; ND = nicotine dependence; OR = odds ratio. 
a The groups were coded into the model as Smokers = 1 and Abstainers = 0.
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cant decrease was observed in craving from pre to post-treat-
ment, followed by a significant increase by 3 month. Howe-
ver, pre-treatment and at 3 months craving did not differ. In 
contrast, among abstainers, we found progressive decline in 
craving between the 3 time points with all differences statis-
tically significant at p < .001. 
Predictors of smoking status at the end of the 
treatment and relapse at 3 months follow-up
For analysing predictors of smoking status at the end of 
the treatment, binary logistic regression was conducted us-
ing those 312 participants with end-of-treatment data, as the 
criterion variable smoking or abstinent and the predictor 
variables ND, NWS-pre, and craving-pre. We found that ND 
was significantly associated with smoking at the end of the 
treatment. Having high ND (OR = 2.28) was associated with 
a significantly increased likelihood of smoking at the end of 
the treatment (see Table 3).
We also examined predictors of relapse at 3 months fo-
llow-up, using a binary logistic regression analysis using the 
162 participants with follow-up data out of the 201 who had 
reached abstinence at the end of the treatment. Adopting as 
the criterion variable smoking or abstinent, and as predictor 
variables ND, craving-pre, NWS-pre, craving-post, and NWS-
post, we found that NWS post was associated with a higher 
risk of relapse. That is, higher NWS at the end of the treat-
ment was associated with a significantly increased likelihood 
of smoking 3 months later (OR = 1.09; see Table 3). 
Discussion
Role of NWS, craving, and ND on the treatment 
outcome
We found that those participants who did not quit smok-
ing at the end of the treatment presented a higher post-treat-
ment NWS and craving for cigarettes than those participants 
who achieved abstinence. This same result has been found 
in previous studies (e.g., Ferguson et al., 2006; Tiffany et al., 
2009) in which high scores in NWS and craving were associ-
ated with failures when quitting smoking. We also observed 
that high pre-treatment ND predicted failure to quit smok-
ing by the end of the treatment.  These results are consistent 
with the robust role of ND in the maintenance of smoking 
behavior (Benowitz, 2010) and the predictive power of ND 
(Ferguson et al., 2003). These results support the statement 
that both NWS and craving, as well as nicotine dependence 
in general, are related to treatment outcome. Indeed, these 
results are consistent with previous studies that established 
craving and NWS as symptoms of dependence and predic-
tors of smoking cessation success (Hughes et al., 1990; Tif-
fany et al., 2009), consistent with DSM-5 criteria. Moreover, 
these relationships between craving, ND, and smoking ces-
sation outcomes are consistent with Robinson et al. (2011) 
who found that more dependent smokers also experienced 
greater craving, and Baker et al. (2012), who considered 
craving as a NWS symptom and as the symptom most associ-
ated with tobacco dependence. 
With respect to the concurrent relationship between 
craving and NWS with smoking at 3 months follow-up, those 
participants who had relapsed presented with significantly 
higher NWS and craving than those who remained absti-
nent. This is contrary to many smokers’ expectations that 
craving and withdrawal symptoms will decrease if they re-
turn to smoking.  However, these uncomfortable effects in 
fact appear more likely to decline if they remain abstinent.  
With respect to predicting relapse among smoker who 
achieved end-of-treatment abstinence, we observed that 
high post-treatment NWS was associated with a greater risk 
of relapse at 3 months. Therefore, as Piasecki et al. (2003b) 
and Shiffman et al. (2004) had pointed out, the NWS that a 
smoker suffers when quitting appears to play an important 
role in the maintenance of abstinence versus relapse. This 
suggests that greater emphasis on controlling NWS, via phar-
macotherapy, education, and coping skills training, may be 
advisable in general, and particularly for those smokers who 
present with high NWS during treatment.  
Evolution of craving and NWS
We found different patterns of change in these two vari-
ables, among both abstainers and continuing smokers be-
tween pre- and post-treatment.  Consistent with other stu-
dies, we found that among abstainers craving decreased 
whereas NWS increased (Etter, 2005; Gilber et al., 1998; Hu-
ghes, 1992; Shiffman et al., 1997) finding different patterns 
of change in craving and NWS among abstaining smokers. 
The increase in NWS is a normal fact giving that they have 
quit smoking and, although the treatment is based on a grad-
ual cessation, any reduction in nicotine intake carries on the 
presence of NWS regardless of a higher or lower intensity. 
Thus, it is necessary to work during the treatment with the 
aim of decreasing NWS as far as possible to avoid relapse 
due to the discomfort generated by these symptoms. An 
important aspect that should be included in the treatment 
is craving decrease. One of the most frequent expectations 
among smokers is that if they give up smoking, craving or 
the desire for the consumption is going to be very intense.
Among continuing smokers, we also found an increa-
se NWS, but no change in craving. The increase in NWS 
among continuing smokers may reflect the reduction in 
smoking (and, therefore, likely nicotine intake) that most 
of the smokers experienced during treatment.  
 With respect to the change in craving and NWS 
from the onset of the treatment until the 3 months fol-
low-up, our results showed that craving decreased signifi-
cantly among abstainers. On the other hand, in those who 
relapse, an increase in craving in the 3 months follow-up 
was found. A similar result was reported by Schlam, Piper, 
Cook, Fiore, and Baker (2012), in which craving continued 
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decreasing in the group of abstainers compared to those 
who continue smoking at one year follow-up. The finding of 
craving increases among relapsers is consistent with studies 
showing that relapses often occur in the presence of an in-
tense craving (Shiffman et al., 1997). Regarding NWS, only 
abstainers showed a decline by 3 months. The continuing 
NWS among relapsers may reflect their continued attempts 
to control their smoking, rather than simply immediately re-
suming their pretreatment patterns of use. It would be very 
interesting to analyze in future studies if this result is due 
to the characteristics of this type of treatment for smoking 
cessation in which the smoker learns different strategies to 
control their smoking behavior or whether NWS remains 
high when relapsing regardless of the method used. 
Limitations 
The study has several limitations. First, we must take care 
with generalizing the results obtained from this treatment 
study, with specific inclusion and exclusion criteria, to the 
general population of smokers. Moreover, it would be in-
teresting to analyze the evolution of craving and NWS in 
smokers who gave up smoking without attending a specific 
treatment and see if there are differences with those who 
used specific procedures. On the other hand, that this spe-
cific sample of Spanish smokers in treatment produced re-
sults consistent with previous research with very different 
samples supports the robustness and generalizability of the 
roles of craving and nicotine withdrawal. Second, the size of 
the sample of relapsers was modest, which may have limited 
our power to detect effects. Finally, our findings are based 
on retrospective, self-reports. However, we employed a wi-
dely-accepted and reliable instrument for the assessment of 
NWS (Shiffman et al., 2004). 
Conclusions 
In summary, evidence indicates that craving decreases as 
the time without smoking increases, but that relapse is as-
sociated with craving increase.  In the case of NWS, a slight 
increase happens when giving up smoking and it decreases 
as length of abstinence increases, whereas it remains high 
among relapsers. Moreover, we found that at the end of the 
treatment, NWS is higher in persons who later relapse than 
among those who do not, although the levels of craving are 
similar between the groups. 
In conclusion, our findings among a Spanish sample of 
smokers provide further support for the robust role of cra-
ving and NWS in smoking cessation and relapse.
Funding
This study was funded by the Spanish Ministry of Science 
and Innovation (Ministerio de Ciencia e Innovación), “National 




Allen, S. S., Bade, T., Hatsukami, D., & Center, B. (2008). 
Craving, withdrawal, and smoking urges on days imme-
diately prior to smoking relapse. Nicotine & Tobacco Re-
search, 10, 35-45. doi:10.1080/14622200701705076
American Psychiatric Association. (1994). Diagnostic and 
statistical manual of mental disorders, (4th ed.). Washing-
ton, D. C.: American Psychiatric Association. 
American Psychiatric Association. (2000). Diagnostic and 
statistical manual of mental disorders, 4th ed., revised text. 
Washington, D. C.: American Psychiatric Association. 
American Psychiatric Association. (2013). Diagnostic and 
statistical manual of mental disorders, 5th Edition: DSM-5. 
Washington D. C.: Author.
Baker, T. B., Breslau, N., Covey, L., & Shiffman, S. (2012). 
DSM criteria for tobacco use disorder and tobac-
co withdrawal: A critique and proposed revisions for 
DSM-5. Addiction, 107, 263-275. doi:10.1111/j.1360-
0443.2011.03657.x
Baker, T. B., Piper, M. E., McCarthy, D. E., Majeskie, M. R., 
& Fiore, M. C. (2004). Addiction motivation reformula-
ted: An affective processing model of negative reinforce-
ment. Psychological Review, 111, 33-51. doi:10.1037/0033-
295X.111.1.33
Becoña, E. (1994). Evaluación de la conducta de fumar 
[Assessment of smoking behaviour]. In J. L. Graña 
(Ed.), Conductas Adictivas: Teoría, evaluación y tratamiento 
(pp. 403-454). Madrid: Debate.
Becoña, E. (2007). Programa para Dejar de Fumar [Smoking 
Cessation Program]. Vigo, Spain: Nova Galicia Edicións.
Becoña, E., & Vázquez, F. L. (1998). The Fagerström Test for 
Nicotine Dependence in a Spanish sample. Psychological 
Reports, 83, 1455-1458. doi:10.2466/pr0.1998.83.3f.1455
Benowitz, N. L. (2010). Nicotine addiction. The New En-
gland Journal of Medicine, 362, 2295-2303. doi:10.1056/
NEJMra0809890
Centers for Disease Control and Prevention (2012). Cu-
rrent Cigarette Smoking Among Adults- United States, 
2011. Morbidity and Mortality Weekly Report, 61, 889-894. 
Cohen, J. (1988). Statistical power analysis for the behavioral 
sciences. Hillsdale, NJ: Erlbaum.
de Leon, J., Becoña, E., Gurpegui, M., Gonzalez-Pinto, 
A., & Diaz, F. J. (2002). The association between high 
nicotine dependence and severe mental illness may be 
consistent across countries. Journal of Clinical Psychiatry, 
63, 812-816.
Etter, J. F., & Hughes, J. R. (2006). A comparison of the 
psychometric properties of three cigarette withdrawal 
scales. Addiction, 101, 362-372. doi:10.1111/j.1360-
0443.2005.01289.x
ADICCIONES, 2014 · VOL. 26 NÚM. 3
237
Bárbara Piñeiro, Ana López-Durán, Elena Fernández del Río, Úrsula Martínez, Thomas H. Brandon, Elisardo Becoña
Ferguson, J. A., Patten, C. A., Schroeder, D. R., Offord, 
K. P., Eberman, K. M., & Hurt, R. D. (2003). Predic-
tors of 6-month tobacco abstinence among 1224 ci-
garette smokers treated for nicotine dependence. 
Addictive Behaviors, 28, 1203-1218. doi:10.1016/S0306-
4603(02)00260-5
Ferguson, S. G., Shiffman, S., & Gwaltney, C. J. (2006). Does 
reducing withdrawal severity mediate nicotine patch ef-
ficacy? A randomized clinical trial. Journal of Consulting 
and Clinical Psychology, 74, 1153-1161. doi:10.1037/0022-
006X.74.6.1153
Gilbert, D. G., McClernon, F. J., Rabinovich, N. E., Plath, L. C., 
Jensen, R. A., & Melisk, C. J. (1998). Effects of smoking abs-
tinence on mood and craving in men: Influences of negati-
ve-affect-related personality traits, habitual nicotine intake 
and repeated measurements. Personality and Individual Dif-
ferences, 25, 399-423. doi:10.1016/S0191-8869(98)00003-8
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fager-
ström, K. O. (1991). The Fagerström Test for Nicotine 
Dependence: A revision of the Fagerström Tolerance 
Questionnaire. British Journal of Addictions, 86, 1119-
1127. doi:10.1111/j.1360-0443.1991.tb01879.x.
Hughes, J. R. (1992). Tobacco withdrawal in self-quitters. 
Journal of Consulting and Clinical Psychology, 60, 689-697. 
doi:10.1037/0022-006X.60.5.689
Hughes, J. R. (2007). Effects of abstinence from tobacco: 
Valid symptoms and time course. Nicotine & Tobacco Re-
search, 9, 315-327. doi:10.1080/14622200701188919
Hughes, J. R., Baker, T., Breslau, N., Covey, L., & Shiffman, 
S. (2011). Applicability of DSM criteria to nicotine de-
pendence. Addiction, 106, 894-895. doi:10.1111/j.1360-
0443.2010.03281.x
Hughes, J. R., & Hatsukami, D. (1998). Errors in using 
tobacco withdrawal scale. Tobacco Control, 7, 92-93. 
doi:10.1136/tc.7.1.92a
Hughes, J. R., Higgins, S. T., & Bickel, W. K. (1994). Nicoti-
ne withdrawal versus other drug withdrawal syndromes: 
Similarities and dissimilarities. Addiction, 89, 1461-1470. 
doi.10.1111/j.1360-0443.1994.tb03744.x
Hughes, J. R., Higgins, S. T., & Hatsukami, D. K. (1990). 
Effects of abstinence from tobacco: A critical review. 
In L. T. Kozlowski, H Annis, H. D. Cappell, F. Glase, M. 
Goodstasdt, Y. Israel (Eds). Research in advances in alcohol 
and drug problems (Vol.10). New York: Plenum. 
Ministerio de Sanidad, Servicios Sociales e Igualdad. 
(2013). Encuesta Nacional de Salud: ENSE 2011-2012. 
http://www.msc.es/estadEstudios/estadisticas/encues-
taNacional/encuesta2011.htm
Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., & 
Baker, T. B. (2003a). Smoking withdrawal dynamics: I. Ab-
stinence distress in lapsers and abstainers. Journal of Abnor-
mal Psychology, 112, 3-13. doi:10.1037/0021-843X.112.1.3
Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C., 
& Baker, T. B. (2003b). Smoking withdrawal dynamics: 
II. Improved tests of withdrawal-relapse relations. Jour-
nal of Abnormal Psychology, 112, 14-27. doi:10.1037/0021-
843X.112.1.14
Robinson, J. D., Lam, C. Y., Carter, B. L., Minnix, J. A., Cui, 
Y., Versace, F., ... Cinciripini, P. M. (2011). A multimod-
al approach to assessing the impact of nicotine depen-
dence, nicotine abstinence, and craving on negative 
affect in smokers. Experimental and Clinical Psychopharma-
cology, 19, 40-52. doi:10.1037/a0022114
Schlam, T. R., Piper, M. E., Cook, J. W., Fiore, M. C., & 
Baker, T. B. (2012). Life 1 year after a quit attempt: 
Real-time reports of quitters and continuing smokers. 
Annals of Behavioral Medicine, 44, 309-319. doi:10.1007/
s12160-012-9399-9
Shiffman, S., Engberg, J. B., Paty, J. A., Perz, W. G., Gnys, 
M., Kassel, J. D., & Hickcox, M. (1997). A day at a time: 
Predicting smoking lapse from daily urge. Journal of 
Abnormal Psychology, 106, 104-116. doi:10.1037/0021-
843X.106.1.104
Shiffman, S., West, R. J., & Gilbert, D. G.; SRNT Work 
Group on the Assessment of  Craving and Withdrawal 
in Clinical Trials (2004). Recommendation for the as-
sessment of tobacco craving and withdrawal in smoking 
cessation trials. Nicotine & Tobacco Research, 6, 599-614. 
doi:10.1080/14622200410001734067
Tiffany, S. T., Warthen, M. W., & Goedeker, K. C. (2009). 
The functional significance of craving in nicotine de-
pendence. In R. A. Bevins, A. R. Caggiula (Eds.), The 
motivational impact of nicotine and its role in tobacco use 
(pp.171-197). Nebraska: Springer.
Toll, B. A., O’Malley, S. S., McKee, S. A., Salovey, P., & Krish-
nan-Sarin, S. (2007). Confirmatory factor analysis of the 
Minnesota Nicotine Withdrawal Scale. Psychology of Ad-
dictive Behaviors, 21, 216-225.
Velicer, W. F., Prochaska, J. O., Rossi, J. S., & Snow, M. G. 
(1992). Assessing outcome in smoking cessation studies. 
Psychological Bulletin, 111, 23-41. doi:10.1037//0033-
2909.111.1.23
West, R., & Hajek, P. (2004). Evaluation of the Mood and 
Physical Symptoms Scale (MPSS) to assess cigarette wi-
thdrawal. Psychopharmacology, 177, 195-199. doi:10.1007/
s00213-004-1923-6
West, R., Hajek, P., Stead, L., & Stapleton, J. (2005). 
Outcome criteria in smoking cessation trials: Propo-
sal for a common standard. Addiction, 100, 299-303. 
doi:10.1016/j.addbeh.2011.11.012.
